MEDIA

Talking about zebrafish

September 2018
12

BIOM

ZeClinics had a successful Japan workshop at BioM

ZeClinics, and eight European SMEs travelled to BioM in Martinsried, to take part in an intensive 4-day Japan workshop from 3-6 September.

View full article
July 2018
23

ASEBIO

ZeClinics y la University of California unen fuerzas contra la epilepsia

ZeClinics SL, ha anunciado un acuerdo de licencia con la Universidad de California, San Francisco (UCSF) para la comercialización de un modelo de epilepsia infantil.

View full article
July 2018
23

UCSF INNOVATION VENTURES

ZeClinics and the University of California, San Francisco (UCSF) Join Forces Against Epilepsy

By combining UCSF’s zebrafish line and ZeClinics’ phenotypic screening expertise, both partners expect to streamline preclinical antiepileptic drug discovery across the world.

View full article
July 2018
23

CORDIS EUROPEAN COMMISSION

ZeClinics and the University of California, San Francisco join forces against epilepsy

License Agreement for the Commercialisation of Zebrafish model for Childhood Epilepsy Will Provide New Opportunities for Novel Antiepileptic Drug Discovery.

View full article
July 2018
03

FRONTIERS

Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline

This review will focus on the most recent advances on CRISPR/Cas9 implementation in zebrafish and all their potential uses in biomedical research and drug discovery.

View full article
April 2018
05

ACCIÓ

El Canadà i el Japó, l’aposta segura del sector ‘biotech’

El sector biotecnològic agrupa a Catalunya unes 500 empreses que representen el 6% del PIB amb una facturació d’11.000 milions d’euros anuals.

View full article
March 2018
19

BIOVOX

Fishing for answers: Screening drug cardiotoxicity using zebrafish

Interview with Dr. Javier Terriente, Chief Scientific Officer at ZeClinics, about some of their most recent projects, including the cardio-analysis technology ZeCardio®.

View full article
March 2018
05

CAMINANDO POR LA CIENCIA

Entrevista radiofónica a Javier Terriente, CSO de ZeClinics

Manolo Castellano, director del programa radiofónico CAMINANDO POR LA CIENCIA, entrevista a Javier Terriente, director científico de ZeClinics.

View full article
February 2018
21

EC SALUD

Aumenta el retorno de las inversiones en el sector biotecnológico

Capital Cell ha gestionado 19 rondas de financiación en las que se han invertido más de 9 millones de euros.

View full article